Attest Laboratories

Attest Laboratories is a medical device startup headquartered in Toronto, Ontario, Canada, developing the next generation of non-invasive biomarker testing technology for people living with diabetes and other metabolic conditions. Its flagship device, myScanLab, uses Magnetic Resonance Spectroscopy (MRS) to test metabolite biomarkers such as glucose and cholesterol from a simple finger scan — without breaking the skin and without disposable strips or sensors. The technology holds a U.S. patent (No. 11,237,237) and targets point-of-care settings such as primary care practices and senior living facilities to enable more frequent screening, improve patient outcomes, and reduce the recurring costs associated with traditional glucose monitoring.